PRKAA2 and cataract: Misra P and Chakrabarti R showed that enhanced AMPK activity improved type 2 diabetes metabolic disorder [27], and our previous studies demonstrated that AKR1B1 overexpression decreased AMPK activation, and increased AcSOD2 and RAGE-induced EMT in the LECs of DM patients with cataracts [5].